Purchases and Sales Made in Q2 2023 in Effector Therapeutics Inc (EFTRW)
This table provides information about the institutional ownership of Effector Therapeutics Inc (EFTRW) during Q2 2023. The information is specifically focused on institutions that hold shares of EFFECTOR THERAPEUTICS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
BUY
|
- |
19.7KNew |
$1.97K - $4.14K
|
19.7K
$0
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 07, 2023
Q2 2023
|
Wolverine Asset Management LLC
|
SELL
|
- |
-1.05K- 7.25% |
$105 - $220
|
13.4K
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Aristeia Capital LLC
Greenwich, CT |
SELL
|
- |
-42.6K- 2.77% |
$4.26K - $8.95K
|
1.5M
$0
|